Deferoxamine Clinical Trials

• Safety & Efficacy of ICL670 vs. deferoxamine in Beta-thalassemia patients with iron overload due to blood transfusions
  ClinicalTrials.gov Identifier: NCT00061750 - Completed
  beta-Thalassemia
  
• A 1-Year Extension Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Effects on Liver Iron Concentration of Deferasirox and Deferoxamine in Children and Adults With Sickle Cell Disease and Transfusional Hemosiderosis
  ClinicalTrials.gov Identifier: NCT00171197 - Active, not recruiting
  Sickle Cell Disease
  
• Combined Chelation Treatment with Deferiprone and Deferoxamine in Thalassemia Major
  ClinicalTrials.gov Identifier: NCT00103753 - Active, not recruiting
  beta-Thalassemia
  
• Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients with Iron Overload due to Blood Transfusions
  ClinicalTrials.gov Identifier: NCT00067080 - Completed
  Anemia, Sickle Cell
  
• Study of Oral ICL670 (Deferasirox) Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
  ClinicalTrials.gov Identifier: NCT00110617 - Active, not recruiting
  Sickle Cell Disease; Iron Overload; Hemolytic Anemia
  
• Deferoxamine for the Treatment of Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00001203 - Active, not recruiting
  Diabetes Mellitus; Heart Disease; Hemochromatosis; Thalassemia
  
• Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
  ClinicalTrials.gov Identifier: NCT00115349 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Thalassemia; Anemia (Cooley''s); beta-Thalassemia
  
• Efficacy Study in Removing Excess Iron from the Heart
  ClinicalTrials.gov Identifier: NCT00105495 - Completed
  Thalassemia Major; Hemosiderosis
  
• Study of ICL670 in iron overload from beta-thalassemia unable to be treated with deferoxamine or chronic anemias
  ClinicalTrials.gov Identifier: NCT00061763 - Completed
  beta-Thalassemia; Myelodysplastic Syndromes; Fanconi Syndrome; Anemia, Diamond-Blackfan; Anemia, Aplastic
  
• Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00000595 - Completed
  Anemia (Iron-Loading); beta-Thalassemia; Hematologic Diseases; Hemoglobinopathies; Thalassemia; Iron Overload; Hemochromatosis